SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that Andy LaFrence, vice president of finance and chief financial officer, will make a presentation to the investment community at the Oppenheimer Healthcare Conference on Wednesday, December 11, 2013, at 8:30 a.m. CT (9:30 a.m. ET) in New York City.
Help employers find you! Check out all the jobs and post your resume.
